stars 1 stars 2 stars 3

SiMPLInext SA acts in the field of advanced cell culture. Current conventional tissue models are unreliable to the point that they cannot be used as in vivo testing replacement. SiMPLInext provides a drop in replacement cell culture insert, which radically enhances the reliability, relevance, reproducibility, scope and quality of data acquired using in vitro models of biological barriers. Our inserts allow to culture better biological barriers, they allow to quality control their function in situ, and they collect the in situ measured data. This allows toxicologists and drug designers to better understand their biological barriers, without impacting processes or protocols.

SiMPLInext SA Questions

The SiMPLInext SA annual revenue was $3 million in 2026.

Silvia Angeloni is the CEO and founder of SiMPLInext SA.

1 people are employed at SiMPLInext SA.

The NAICS codes for SiMPLInext SA are [54, 5417, 541].

The SIC codes for SiMPLInext SA are [87, 873].

Top SiMPLInext SA Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users